Back
Allegiant Travel 10K Form
Sell
28
ALGT
Allegiant Travel
Last Price:
$83.20
Seasonality Move:
-2.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | ALGT/Allegiant Travel Quarterly |
2024-03-08 | 10K | ALGT/Allegiant Travel Annual |
2024-02-29 | 10K | ALGT/Allegiant Travel Annual |
2023-11-08 | 10Q | ALGT/Allegiant Travel Quarterly |
2023-08-07 | 10Q | ALGT/Allegiant Travel Quarterly |
2023-05-08 | 10Q | ALGT/Allegiant Travel Quarterly |
Receive ALGT News And Ratings
See the #1 stock for the next 7 days that we like better than ALGT
ALGT Financial Statistics
Sales & Book Value
Annual Sales: | $2.5B |
---|---|
Cash Flow: | $-28.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $59.39 |
Price / Book: | 1.4 |
Profitability
EPS (TTM): | -13.37000 |
---|---|
Net Income (TTM): | $-240.2M |
Gross Margin: | $384.9M |
Return on Equity: | -18.85% |
Return on Assets: | -5.91% |
Allegiant Travel Earnings Forecast
Key Allegiant Travel Financial Ratios
-
The Gross Profit Margin over the past 21 years for ALGT is 15.32%.
-
The Selling, General & Administrative Expenses for ALGT have been equal to 4.23% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of ALGT is -9.56% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 13 years.
Allegiant Travel Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Passenger Airlines |
Sector: | Industrials |
Current Symbol: | ALGT |
CUSIP: | 01748X |
Website: | allegiant.com |
Debt
Debt-to-Equity Ratio: | 1.9 |
---|---|
Current Ratio: | 1.72 |
Quick Ratio: | 1.72 |
Price-to-Earnings
Trailing P/E Ratio: | 15.76 |
---|---|
Forward P/E Ratio: | 8.8 |
ALGT Technical Analysis vs Fundamental Analysis
Sell
28
Allegiant Travel (ALGT)
is a Sell
Is Allegiant Travel a Buy or a Sell?
-
Allegiant Travel stock is rated a SellThe current Allegiant Travel [ALGT] share price is $83.26. The Score for ALGT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.